Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1221-1240 of 1,334 trials

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

NCT01293461

The purpose of this study is to assess safety and tolerability and determine the pharmacokinetics of subcutaneous single and multiple (up to 12) dose administration of CBX129801 (long-acting synthetic C-peptide) in type 1 diabetes patients.

Type 1 DiabetesDiabetes MellitusPeripheral Diabetic Neuropathy

Cebix Incorporated72 participantsStarted Apr 2011

Escondido, California, United States • Tustin, California, United States • Walnut Creek, California, United States +5 more locations

COMPLETEDPHASE2< 1 mile

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

NCT00084630

This phase II trial is studying how well imatinib mesylate works in treating patients with locally recurrent or metastatic dermatofibrosarcoma protuberans (DFSP) or transformed fibrosarcomatous DFSP (a type of soft tissue sarcoma). Imatinib mesylate may stop the growth of tumor cells by blocking the enzymes necessary for their growth

Adult FibrosarcomaDermatofibrosarcoma ProtuberansRecurrent Adult Soft Tissue Sarcoma+1 more

National Cancer Institute (NCI)40 participantsStarted May 2004

San Antonio, Texas, United States

COMPLETEDPHASE1< 1 mile

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

NCT00003765

Phase I trial to study the effectiveness of O6-benzylguanine and carmustine in treating children who have refractory CNS tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Brain and Central Nervous System Tumors

National Cancer Institute (NCI)36 participantsStarted May 1999

Little Rock, Arkansas, United States • La Jolla, California, United States • Los Angeles, California, United States +53 more locations

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Rheumatoid Arthritis Trials in Other Cities

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

FS VH S/D 500 S-apr in Vascular Surgery

INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

Fecal Biomarker Study for Patients With Ulcerative Colitis

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).

Other Conditions in San Antonio